Manhattan condos $1,629/sf 2%Manhattan co-ops $283K/room 5%Central Park perimeterPark Ave $478K/room 19%CPW $350K/room 5%Fifth Ave $501K/room 19%Billionaires' Row $4,272/sf 24%East Village $1,663/sf 10%
Full index →
The Pfizer Building (235 East 42nd Street), 235 East 42nd Street, New York, NY 10017, Manhattan — Office-to-residential conversion
Buildings·Midtown East·Office-to-residential conversion

The Pfizer Building (235 East 42nd Street)

235 East 42nd Street, New York, NY 10017

BBL 1013160023 · BIN 1037552

CorridorMidtown East
At a glance
Type
Office-to-residential conversion

For half a century, 235 East 42nd Street was corporate rather than residential — the global headquarters of Pfizer, an anonymous Midtown East office block a block from Grand Central. Its second life is what makes it consequential: paired with the older, lower building next door at 219 East 42nd Street, it is being converted into what is positioned as the largest office-to-residential conversion in New York City history, on the order of 1,500 apartments.

That scale is the story. Midtown East is the epicenter of the post-pandemic thesis that Manhattan's surplus of dated Class-B office space can be re-tenanted with housing, and the former Pfizer campus is the single most ambitious test of it — a project whose size, financing, and affordable-housing component have made it a reference point for the entire conversion cycle. For a renter, the appeal is straightforward: brand-new residential systems and a deep amenity package inside a Grand Central-adjacent address, at a rental (rather than for-sale) product tier.

Architecture and unit composition

The assemblage joins two very different structures. 219 East 42nd Street is the older, lower building — a mid-century block of roughly ten stories. 235 East 42nd Street is the taller tower that carried Pfizer's headquarters operation. The conversion plan reconfigures both: the design calls for recladding the taller tower in a new, high-performance facade and, on the lower building, adding a substantial vertical extension — reported at roughly nineteen new stories atop the original ten — so that the combined project reads as a single, much larger residential complex rather than two aging office boxes.

Office-to-residential conversion at this scale is difficult engineering. Deep office floor plates have to be cut and reorganized to bring light and air to residential layouts; mechanical, plumbing, and life-safety systems are effectively rebuilt; and facades are frequently stripped and replaced. The Pfizer project compounds that difficulty by also adding height — new residential floors carried atop an existing structure — which places new demands on the building's structural frame.

The conversion is designed by Gensler. The published program pairs a rebuilt residential envelope with an amenity package reported in excess of 100,000 square feet — a rooftop pool, a fitness center, resident lounges and work spaces, and ground-floor retail — alongside the affordable-housing component that anchors the project's use of New York's conversion-incentive programs. The residences are planned as market-rate and affordable rentals; this is not a condominium offering, and there is no for-sale sponsor plan associated with the building.

Building operations

As of July 2026 the project is under construction and not yet leasing, and its near-term status is complicated by the structural situation described in the note at the foot of this page. For anyone tracking the building — as a prospective renter, a neighbor, or a market observer — this is an active construction site whose completion timeline should be treated as unsettled until the current conditions are resolved and the Department of Buildings signs off on the structure. The Roebling Team monitors the Midtown East conversion pipeline and can share what is publicly known as the situation develops.

Local Law 97

Carbon-penalty exposure
🟢
Strong — under cap in both periods
2024–2029 annual penalty
$0 (under cap)
2030–2034 annual penalty
$0 (under cap)
Per unit / month range
See full Local Law 97 analysis — emissions history, scenarios, methodology →

Facade safety — Local Law 11

Local Law 11 / FISP · last inspection 2020–25
SWARMP
What this means for you

The latest available filing classified the facade as SWARMP — Safe With A Repair and Maintenance Program: the engineer identified conditions requiring monitoring or repair before the next inspection cycle. The scope, timeline, and how the building funds the work are building-specific — we review the filings and board materials for you.

Inspection history
2005–10
Safe
2010–15
SWARMP
2015–20
SWARMP
2020–25
SWARMP
2025–30
Due
Next report due
by Feb 2027
The three grades, in buyer terms
SafeLatest filing: Safe — no repairs required at that inspection.
SWARMPLatest filing: repairs required before the next inspection cycle.
UnsafeLatest filing: unsafe conditions requiring corrective action.

QEWI = Qualified Exterior Wall Inspector — the licensed engineer the city requires to sign the report (the independent expert, not the managing agent). Source: NYC DOB facade filings (FISP) · The Roebling Research Library.

See the full facade history →
Follow this building

Be first to know when The Pfizer Building (235 East 42nd Street) launches

There are no sponsor sales yet. Register below and we’ll reach out the moment pricing and the offering plan are released — before the building is on the open market.

We’ll only use your email to reach out about this building and closely related inventory. See our privacy policy.

Comparable buildings

The former Pfizer HQ sits within a broader wave of Manhattan office-to-residential conversions — among them One Wall Street, 25 Water Street, 160 Water Street, and 20 Broad Street downtown, and, in Tribeca, the completed conversion at 108 Leonard Street. What distinguishes 235 East 42nd Street is size: it is larger than any of them, which is precisely why both its ambition and its construction challenges carry outsized attention. We map that cycle — the economics, the incentives, and the pipeline the former Pfizer campus anchors — in the Roebling Report's From Boardrooms to Bedrooms: NYC's Office Makeover.


Note — structural situation reported July 2026. On July 7, 2026, the New York City Fire Department responded to 235 East 42nd Street after reports of bricks falling from the building, which is under construction. According to the emergency response and Department of Buildings activity that followed, two structural columns buckled at roughly the 21st and 22nd floors, with floors reported sagging between about the 21st and 26th floors, and portions of the interior structure reported to have partially given way. The Fire Department declared a major technical-rescue operation, construction workers were evacuated, and several surrounding buildings were evacuated as a precaution while engineers assessed whether the instability could spread and whether a partial collapse was possible.

This note reflects conditions as publicly reported at the time of writing and is provided for transparency, not as a final engineering determination. It is an evolving situation; the cause, the extent of the damage, responsibility, and the effect on the project's timeline had not been formally established as of this writing, and nothing here alleges fault by any party. The Roebling Team at Compass does not represent the ownership, developer, or construction team of 235 East 42nd Street; this page is provided for research purposes and is not legal, engineering, or safety advice. Anyone relying on it should confirm the building's current status directly against New York City Department of Buildings records before making any decision.

The neighborhood

For the full corridor — architecture, schools, transit, and pricing across Midtown East — read The Roebling Team Guide to Midtown East.

Considering a move at The Pfizer Building (235 East 42nd Street)?

Request a private building brief with the relevant comparable sales, current and off-market availability, and an apartment-specific view of value.

Prefer to speak directly? Schedule a consultation →
Corey Cohen, Principal · The Roebling Team at Compass
646.939.7375 · c.cohen@compass.com
Considering a sale?

Own an apartment here? See what it would sell for.

A Private Pricing Opinion — what your apartment at The Pfizer Building (235 East 42nd Street) would likely sell for today, what it costs to sell, and what you’d walk away with — reviewed personally against condition, exposures, renovation quality, and the competition actually on the market.